[1] |
HE Lihua, ZHU Xiuzhi, JIANG Yizhou.
Research progress on immunotherapy for triple-negative breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(8): 842-853.
|
[2] |
HOU Qiong, LIU Fei, CHEN Chuanrong.
Immunotherapy combined with anti-angiogenic drugs and chemotherapy in negative driver gene and advanced non-small cell lung cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 775-779.
|
[3] |
WANG Dan, YAN Xiaoli, ZHANG Yuan.
Helicobacter pylori infection influences the efficacy of immunotherapies for gastric cancer#br#
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(2): 228-234.
|
[4] |
LI Wei, HU Jiali, WANG Kai, HE Yijing.
Research progress and prospect of immunotherapy in the treatment of melanoma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 1053-1064.
|
[5] |
MIN Hang, GUO Mengran, YE Yue, XU Xiaoshuang, ZHEN Donghu.
Research progress of thyroid dysfunctions during treatment with immune-checkpoint inhibitors
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(2): 223-229.
|
[6] |
ZHAO Quanming, YANG Yang.
Progress in drug therapy for advanced triple-negative breast cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(4): 475-480.
|
[7] |
CHANG Xiangxiang, WEI Zhongling, ZHENG Xingyuan, LI Huimin, HUANG Laiquan.
Progress in the treatment of multiple myeloma
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(1): 107-116.
|
[8] |
ZHANG Kaiting, CHEN Naihan.
Development of therapeutic biologics in cancer treatment
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(1): 32-43.
|
[9] |
ZHANG Xiaoying, WANG Kang, WU Sha, GUO Peng.
Association analysis of low dose olanzapine in controlling mental symptoms of NMDAR encephalitis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(11): 1292-1296.
|
[10] |
WANG Weili,LIAO Ping, XU Biaobo,ZHOU Chengfang, XIE Shangchen, SHEN Dongya, HE Yijing, Howard L. Mcleod.
Research progress of personalized medicine for immune checkpoint blockades
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(2): 228-232.
|
[11] |
WANG Jun, LIU Wei-bei, CI Chao, CHANG Xiao-li, HE Cai-feng, QIANG Di, HANG Shou-yun, JI Bi-hua.
Clinical observation of CO2 laser combined with ALA photodynamic therapy for recurrent perianal Condyloma Acuminatum
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(3): 322-324.
|
[12] |
XIE Dong, HE Li-hua, CHENG Ze-neng, WU Wei, GUO Xin, LIU Zhi.
Topical accumulation of aminolevulinic acid in moderate to severe acne patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(10): 1132-1137.
|
[13] |
SONG Li-bin, HE Deng-quan, SHEN Min-he.
Empirical study of photodynamic therapy combined with cinobufotalin on transplanted H22 liver cancer by observing its influence on motilin,gastrin
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(1): 30-33.
|
[14] |
WANG Zi-hao, WANG Xue-feng, JIANG Han, WANG Jina-dong, SHI Wei-bin.
Domestic clinical research progress of photosensitive anticancer drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(1): 107-111.
|
[15] |
CHEN Cun-guo, LI Shao-bo, WANG Xin-xin, JIN Xiao-hong, TONG Xia-sheng, LAI Xiao-ying.
Effects of specific immunotherapy on IL-10 and CD4+CD25+ regulatory T cells in asthmatic rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(8): 871-875.
|